Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Making Sense of Autoimmune Sensorineural Hearing Loss

Bryn Nelson, PhD  |  Issue: October 2024  |  October 8, 2024

A systematic review found that methotrexate “appears to be more efficacious in treating vestibular symptoms.”6 So far, no definitive evidence has emerged to suggest an efficacious non-steroidal treatment for the hearing loss.

Making the Right Referral

Even for a specialist, patients with autoimmune SNHL are fairly rare. “Let me put it this way: I more commonly see people who are erroneously diagnosed with autoimmune inner ear disease than I do people with true autoimmune inner ear disease,” says Dr. Rubinstein.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Otologists commonly misdiagnose the condition in patients with sudden SNHL, which doesn’t have rapidly progressive symptoms and typically isn’t bilateral, but can respond to glucocorticoids. The problem, according to Dr. Rubinstein, is that clinicians often refer such patients to a rheumatologist for treatment with another immune modulator before properly differentiating between the two conditions.

“They’ll be on that treatment for years,” he says. “I’ll see them, and usually they come with a pile of hearing tests, and at that point, I’ll say, ‘I think we should stop the medication that you’re on and see what happens. If it’s really autoimmune, your hearing may drop, and then we’ll know for sure, and we’ll put you back on it and you won’t have lost anything. But it might enable you to get off this relatively toxic stuff that you’re taking.’”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In an ideal setting, he says, such a patient would be referred by one of his colleagues instead of a rheumatologist. “But the classic situation [in which] a rheumatology referral is great is if a rheumatologist is treating someone for a known autoimmune condition, say rheumatoid arthritis, and then the person develops rapidly progressive hearing loss,” Dr. Rubinstein says. “That’s the perfect situation to make the diagnosis easily and get the person treated.”

Dr. Rubinstein typically doesn’t refer a patient with autoimmune inner ear disease to a rheumatologist unless he can’t get them off prednisone or they have other symptoms beyond hearing loss that are suggestive of other diseases. “It’s worth experimenting a little bit to see if there’s some other drug where, even though it’s unproven, in their particular case [may] allow them to get off steroids,” he says.

If Dr. Rubinstein strongly suspects the hearing loss is autoimmune in nature but the patient doesn’t respond to glucocorticoids, he may consult with a rheumatologist to seek alternatives. “Generally nothing works in that setting. However, that doesn’t mean I wouldn’t give it a try,” he says.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic ConditionsVasculitis Tagged with:autoimmune inner ear diseaseautoimmune sensorineural hearing loss (SNHL)hearing loss

Related Articles
    SSNHL was first described in 1979 in a series of 18 patients from Iowa whose acute hearing loss was not explained by the usual causes.

    When Sense Disorders Signal Immune System Interactions

    November 17, 2015

    I sometimes find myself mired in sticky clinical circumstances. I am facing a distraught patient who is seeking my opinion about a condition that, according to some, may not truly belong in the rheumatologist’s bailiwick. Case example: hearing loss. The Steroid Test Sudden sensorineural hearing loss (SSNHL) and its relative, autoimmune inner ear disease (AIED),…

    The High Stakes of Brain, Ear, Eye Syndromes

    July 31, 2024

    Experts detailed the diagnosis and treatment of two patients with Susac syndrome, a brain, ear, eye syndrome. They also provided insights into the complexities of these conditions, why they are difficult to diagnose and key points for practicing rheumatologists.

    Risk of Hearing Loss in Patients with Osteoporosis

    September 15, 2015

    People diagnosed with osteoporosis have almost twice the risk of developing hearing loss as those without the bone-fragile skeletal disease, according to results from a large retrospective study in Taiwan. The study looked at the risk of sudden sensorineural hearing loss (SSHL) using data collected from Taiwan’s National Health Insurance claims and is believed to…

    Old Drugs Can Learn New Tricks

    November 1, 2011

    Methotrexate and its mechanism of action

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences